Dry Granulation Excipient Market Share

APAC Market Forecast

The dry granulation excipients market in the Asia Pacific region is anticipated to hold the largest share of about ~34% by the end of 2036. The market growth in the region is also expected on account of the rapidly expanding pharmaceutical industry in countries like China, Indonesia, India, Japan, and South Korea. Studies show that there are 3000 FDA-approved pharmaceutical companies in India additionally in South Korea, there were 653 pharmaceutical companies in 2022. This growth of the pharmaceutical industry can be attributed to the rising prevalence of chronic disease due to unhealthy lifestyles and high population rates in the region. Furthermore, countries in the Asia Pacific region like India which has one of the largest pharmaceutical industries in the world are hubs for generic drug manufacturing. This is due to the presence of major key players in the region, catering to both domestic and international markets. Dry granulation excipients are essential for formulating generic drugs, and the region's growing focus on generic pharmaceuticals contributes to the demand for these excipients.

European Market Analysis

The European dry granulation excipients market is estimated to be the second largest, registering a share of about ~24% by the end of 2036. The market’s expansion can be attributed majorly to the growing emphasis on superior generic pharmaceutical products due to economic pressure and healthcare cost containment efforts. For instance, currently, generic drugs account for around 50% of the European market by volume. Furthermore, the demand for oral solid dosage formulations in the region's growing aging population and the rising prevalence of chronic disease is also expected to propel the market growth. Moreover, the European region offers a conducive environment for the growth of the dry granulation excipient market, driven by stringent regulatory standards, increasing demand for oral solid dosage forms, advancements in pharmaceutical manufacturing, focus on patient compliance, high-quality drug delivery system, outsourcing trends, and innovation in drug delivery systems.